• 1
    ProtecT Study (Prostate testing for cancer and Treatment). Available at: Accessed January 2013
  • 2
    Cooperberg MR, Ramakrishna NR, Duff SB et al. Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis. BJU Int 2013; 111: 437450
  • 3
    Hummel S, Paisley S, Morgan A, Currie E, Brewer N. Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review. Health Technol Assess 2003; 7: iii, ix–x, 1–157
  • 4
    Ho C, Tsakonas E, Tran K, et al. Robot-assisted surgery compared with open surgery and laparoscopic surgery: clinical effectiveness and economic analyses [Document on the internet]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2011 (Technology report no. 137). Available at: Accessed May 2012
  • 5
    Flattery M, Harrington P, O'Neill M, et al. Health technology assessment of robot-assisted surgery in selected surgical procedures [Document on the internet]. Dublin: Health Information and Quality Authority Health Technology Assessment Directorate; 2011. Available at: Accessed May 2012
  • 6
    Ramsay C, Pickard R, Robertson C, et al. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess 2012; 16: 1313.